Erin McCann

[Erin McCann @ErinMcCann78]

Just finished listening to this episode of @TopMedTalk. The conversation with Dr. Seenu Reddy about his study examining the impact of Acumen HPI in cardiac enhanced recovery pathways was inspiring. #cardiacsurgery Listen to the podcast: https://t.co/ivLubvOKpM

[Erin McCann @ErinMcCann78]

We hope to see you in Phoenix at #SCCM2024. We’ll be showcasing the latest innovative technologies designed to help you #stayahead of critical moments and improve patient care. Visit us to experience the power of continuous monitoring: https://t.co/nijZjL70el

[Erin McCann @ErinMcCann78]

We can’t wait to see you at #SCCM2024! Come see live product demonstrations, learn how you can manage hemodynamic instability, and view patient insights remotely. Learn more: https://t.co/AFdFAKVZi7

[Erin McCann @ErinMcCann78]

At #SCCM2024 don’t miss your chance to see a demo of how our innovative technology displays advanced hemodynamics with comprehensive monitoring to help you make proactive decisions for your patients. Learn more: https://t.co/n7eA8kmARP

[Erin McCann @ErinMcCann78]

How do you #stayahead of hemodynamic instability? Demo the all-in-one smart monitor with software that can help detect hemodynamic instability in your patients: https://t.co/P3PGrAHDLt

[Erin McCann @ErinMcCann78]

Despite guideline recommendations, a study revealed that only 26% of patients with symptomatic severe #aorticregurgitation received surgical aortic valve replacement (#SAVR) within 1 year of diagnosis. Read the blog post about timely intervention at https://t.co/78Q56dcTuE

[Erin McCann @ErinMcCann78]

Whether you’re working, on call, or on holiday, the #EdwardsLifesciences team wishes all #healthcareproviders a very #HappyNewYear. May 2024 bring you the best outcome yet!

[Erin McCann @ErinMcCann78]

#HappyHolidays! As things quiet down, we’re reflecting on an incredible year of patient-focused care and #innovation. From the #EdwardsLifesciences team to you and yours, may the holiday season bring you joy, peace, and abundant health.

[Erin McCann @ErinMcCann78]

According to a study, the discounted cost savings when using a #RESILIAtissue valve vs. a mechanical valve for #SAVR is projected to be ~$20,000 at 15 years. Learn more in the latest blog post at https://t.co/FiLzxakbil

[Erin McCann @ErinMcCann78]

Study shows design variations in similarly-sized #bioprosthetic mitral valves – MITRIS RESILIA, Epic, and Mosaic valves. Only the MITRIS RESILIA valve had similar internal dimensions within the atrial and ventricular portions of the valve frame. Learn more https://t.co/sCAjOseg7f

[Erin McCann @ErinMcCann78]

#Thanksgiving is a time to celebrate the past year’s blessings. On this special holiday we’re celebrating all the #healthcareproviders working to create a healthier world. What are you celebrating this Thanksgiving?

[Erin McCann @ErinMcCann78]

A future of possibility. That’s what #RESILIA tissue brings. Discover the difference with dry storage for simpler handling, enhanced anti-calcification technology, and the potential to avoid surgical re-intervention later in life.* Learn more at https://t.co/kS4dtSEjZw

[Erin McCann @ErinMcCann78]

Evidence in support of #RESILIAtissue valves is growing. Data from the #COMMENCE #aortic and #mitral trials show results vs other aortic bioprostheses , 7-year outcomes in the aortic position, and 5-year outcomes in the mitral position.* Learn more at https://t.co/RpkaVR7QeE

[Erin McCann @ErinMcCann78]

The #COMMENCE #aortic and #mitral trials continue to demonstrate the durability of #RESILIAtissue valves. Check out the latest data, including 7-year outcomes in the aortic position and 5-year outcomes in the mitral position. https://t.co/RpkaVR7QeE

[Erin McCann @ErinMcCann78]

Have you seen the 7-year data from the #COMMENCE #aortic trial? Download the infographic for study methods, patient demographics, and key results showing what’s possible with #RESILIAtissue valves. https://t.co/fqdkaTImdj

[Erin McCann @ErinMcCann78]

The 7-year data from the #COMMENCE #aortictrial represents the longest follow-up after #AVR with #RESILIAtissuevalves in a large IDE trial. Check out the excellent outcomes, including clinically stable hemodynamics and 99.3% freedom from #SVD at 7 years. https://t.co/fqdkaTImdj

[Erin McCann @ErinMcCann78]

View hemodynamic insights for multiple patients from the palm of your hand on your smartphone with Viewfinder remote app. Viewfinder platform can now connect HemoSphere monitors directly to your hospital’s EMR system. Learn more at #ANES23 https://t.co/3ssY5xEYnq

[Erin McCann @ErinMcCann78]

❗️Make sure your ANESTHESIOLOGY® 2023 schedule includes a stop at booth 527! We’re looking forward to sharing the latest updates to our smart, all-in-one #hemodynamic monitoring platform. Learn more: https://t.co/6KcJ7QILnC #ANES23 #anesthesiology

[Erin McCann @ErinMcCann78]

#ANES23 is a great opportunity to demo a predictive algorithm for managing intraoperative hypotension. Stop by booth 527 to see firsthand how Acumen™ Hypotension Prediction Index software can empower proactive hemodynamic management. Learn more: https://t.co/kFyRr0XUqt

[Erin McCann @ErinMcCann78]

Planning your time at ANESTHESIOLOGY® 2023? Come see us at booth 527 and demo our all-in-one #hemodynamicmonitoring platform. We’re excited to show you how smart monitoring can make a difference for patients. Learn more: https://t.co/SWhPtrxTmk #ANES23 #anesthesiology